ARTICLE | Company News
Harvard Bio, Mitoscan Corp. deal
January 2, 2001 8:00 AM UTC
HBIO acquired Mitoscan for a $300,000 upfront payment plus contingent payments and royalties. Mitoscan's high throughput toxicology screening technology will complement HBIO's drug discovery supply bu...